Monovalent (Original Formulation) mRNA Vaccines No Longer Authorized for Boosters
Monovalent (Original Formulation) mRNA Vaccines No Longer Authorized for Boosters
An important note: Monovalent mRNA COVID-19 vaccines are NO LONGER authorized for use as boosters in people ages 12 years and older.
- From the FDA press release: With today’s authorization, the monovalent mRNA COVID-19 vaccines are not authorized as booster doses for individuals 12 years of age and older.
Appointments for monovalent Pfizer-BioNTech or Moderna boosters in people 12 years of age and older must be rescheduled for when locations have the bivalent COVID-19 vaccines available.
Please check out the FDA landing pages below for updated EUAs for existing products and new EUAs for the bivalent products.- Pfizer: Pfizer-BioNTech COVID-19 Vaccines | FDA
- Moderna: Moderna COVID-19 Vaccines | FDA
Remember: Bivalent vaccines cannot be administered until ACIP convenes and makes formal recommendations (expected tomorrow or Thursday).